Skip to main content

Advertisement

SpringerLink
Log in

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients

  • Original Contribution
  • Published:
Diseases of the Colon & Rectum

PURPOSE

The matrix metalloproteinases and their inhibitors are known to be involved in the process of tumor invasion and progression. Our objective was to investigate the potential diagnostic and prognostic value of plasma matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 in colorectal cancer.

METHODS

Gelatinase bioactivity and immunoreactivity of pro-matrix metalloproteinase-2 and -9, tissue inhibitor of metalloproteinase-1, and carcinoembryonic antigen were determined simultaneously in preoperative plasma and serum of colorectal cancer patients (n = 94) and in healthy controls (n = 51).

RESULTS

Plasma pro-matrix metalloproteinase-2 levels were lower in colorectal cancer patients (P < 0.0001) than in controls, and its gelatinolytic activity revealed an inverse correlation with adverse clinicopathologic parameters, such as lymph node involvement (P = 0.017), stage (0, I, II vs. III, IV; P = 0.012), and the carcinoembryonic antigen level (P = 0.016). Pro-matrix metalloproteinase-9 levels did not differ between patients and controls. Pro-matrix metalloproteinase-2 gelatinolytic activity showed potential value in colorectal cancer diagnosis, identifying patients with 70 percent sensitivity at 95 percent specificity. Pro-matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and carcinoembryonic antigen all showed lower sensitivities. Combining pro-matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 measurements increased the sensitivity significantly to 84 percent. With respect to prognosis, tissue inhibitor of metalloproteinase-1 showed value in predicting disease outcome in our patient group, whereas pro-matrix metalloproteinase-2 and -9 did not. The combination of tissue inhibitor of metalloproteinase-1 and carcinoembryonic antigen was better in predicting three-year survival than tissue inhibitor of metalloproteinase-1 alone, but it remains to be determined if the combination would be a better marker for survival than carcinoembryonic antigen alone.

CONCLUSIONS

Low pro-matrix metalloproteinase-2 levels and high tissue inhibitor of metalloproteinase-1 levels correlate with parameters of colorectal cancer disease. These correlations may be used in the search for new markers in colorectal cancer diagnosis and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Figure 2.

Similar content being viewed by others

REFERENCES

  1. HL McLeod GI Murray (1999) ArticleTitleTumor markers of prognosis in colorectal cancer Br J Cancer 79 191–203 Occurrence Handle1:STN:280:DyaK1M7gtlGgsA%3D%3D Occurrence Handle9888457

    CAS  PubMed  Google Scholar 

  2. YA DeClerck (2000) ArticleTitleInteractions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer Eur J Cancer 36 1258–68 Occurrence Handle10.1016/S0959-8049(00)00094-0 Occurrence Handle1:CAS:528:DC%2BD3cXksFCrsrc%3D Occurrence Handle10882864

    Article  CAS  PubMed  Google Scholar 

  3. ZS Zeng AM Cohen JG Guillem (1999) ArticleTitleLoss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP- 9) during human colorectal tumorigenesis Carcinogenesis 20 749–55 Occurrence Handle10.1093/carcin/20.5.749 Occurrence Handle1:CAS:528:DyaK1MXjtVantLs%3D Occurrence Handle10334190

    Article  CAS  PubMed  Google Scholar 

  4. D-EJ Kleiner A Tuuttila K Tryggvason WG Stetler-Stevenson (1993) ArticleTitleStability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2) Biochemistry 32 1583–92 Occurrence Handle10.1021/bi00057a024 Occurrence Handle1:CAS:528:DyaK3sXhs1CisLs%3D Occurrence Handle8431437

    Article  CAS  PubMed  Google Scholar 

  5. GI Goldberg BL Marmer GA Grant AZ Eisen S Wilhelm CS He (1989) ArticleTitleHuman 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2 Proc Natl Acad Sci USA 86 8207–11 Occurrence Handle1:CAS:528:DyaK3cXltFWgsg%3D%3D Occurrence Handle2554304

    CAS  PubMed  Google Scholar 

  6. ZS Zeng AM Cohen ZF Zhang SW Stetler JG Guillem (1995) ArticleTitleElevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases Clin Cancer Res 1 899–906 Occurrence Handle1:CAS:528:DyaK2MXnsVeqsLs%3D Occurrence Handle9816060

    CAS  PubMed  Google Scholar 

  7. MN Holten-Andersen RW Stephens HJ Nielsen et al. (2000) ArticleTitleHigh preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer Clin Cancer Res 6 4292–9 Occurrence Handle1:CAS:528:DC%2BD3cXovVSgur0%3D Occurrence Handle11106246

    CAS  PubMed  Google Scholar 

  8. MN Holten-Andersen IJ Christensen HJ Nielsen et al. (2002) ArticleTitleTotal levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer Clin Cancer Res 8 156–64 Occurrence Handle1:CAS:528:DC%2BD38XhsVKmurg%3D Occurrence Handle11801553

    CAS  PubMed  Google Scholar 

  9. A Oberg M Hoyhtya B Tavelin R Stenling G Lindmark (2000) ArticleTitleLimited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer Anticancer Res 20 1085–91 Occurrence Handle1:CAS:528:DC%2BD3cXjtl2ku78%3D Occurrence Handle10810401

    CAS  PubMed  Google Scholar 

  10. M Lein L Nowak K Jung et al. (1997) ArticleTitleAnalytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood Clin Biochem 30 491–6 Occurrence Handle1:CAS:528:DyaK2sXmslyhtrc%3D Occurrence Handle9316744

    CAS  PubMed  Google Scholar 

  11. K Jung M Lein A Roemer R Lichtinghagen (2002) ArticleTitleCirculating gelatinase B (MMP-9)—the impact of the preanalytical step of blood collection Matrix Biol 21 381–2 Occurrence Handle1:CAS:528:DC%2BD38XmvVCrurw%3D Occurrence Handle12225801

    CAS  PubMed  Google Scholar 

  12. S Zucker RM Lysik MH Zarrabi U Moll (1993) ArticleTitleM(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Res 53 140–6 Occurrence Handle1:STN:280:ByyC3crktVU%3D Occurrence Handle8416738

    CAS  PubMed  Google Scholar 

  13. S Zucker RM Lysik BI DiMassimo et al. (1995) ArticleTitlePlasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer Cancer 76 700–8 Occurrence Handle1:CAS:528:DyaK2MXnsFCks70%3D Occurrence Handle8625169

    CAS  PubMed  Google Scholar 

  14. MG Tutton ML George SA Eccles S Burton RI Swift AM Abulafi (2003) ArticleTitleUse of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients Int J Cancer 107 541–50 Occurrence Handle1:CAS:528:DC%2BD3sXoslequ7s%3D Occurrence Handle14520690

    CAS  PubMed  Google Scholar 

  15. E Farias S Ranuncolo C Cresta et al. (2000) ArticleTitlePlasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients Int J Cancer 89 389–94 Occurrence Handle1:CAS:528:DC%2BD3cXlvFagtr4%3D Occurrence Handle10956415

    CAS  PubMed  Google Scholar 

  16. WC Duivenvoorden HW Hirte G Singh (2001) ArticleTitleQuantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study Int J Cancer 91 857–62 Occurrence Handle1:CAS:528:DC%2BD3MXhsFGjt78%3D Occurrence Handle11275992

    CAS  PubMed  Google Scholar 

  17. L Kjeldsen AH Johnsen H Sengelov N Borregaard (1993) ArticleTitleIsolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase J Biol Chem 268 10425–32 Occurrence Handle1:CAS:528:DyaK2cXpvFKqsA%3D%3D Occurrence Handle7683678

    CAS  PubMed  Google Scholar 

  18. ET Waas RM Lomme J DeGroot T Wobbes T Hendriks (2002) ArticleTitleTissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer Br J Cancer 86 1876–83 Occurrence Handle1:CAS:528:DC%2BD38XkvVaiu7Y%3D Occurrence Handle12085179

    CAS  PubMed  Google Scholar 

  19. ER DeLong DM DeLong DL Clarke-Pearson (1988) ArticleTitleComparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 837–45 Occurrence Handle1:STN:280:BiaD2snpslc%3D Occurrence Handle3203132

    CAS  PubMed  Google Scholar 

  20. AF Chambers LM Matrisian (1997) ArticleTitleChanging views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst 89 1260–70

    Google Scholar 

  21. T Itoh M Tanioka H Matsuda et al. (1999) ArticleTitleExperimental metastasis is suppressed in MMP-9-deficient mice Clin Exp Metastasis 17 177–81 Occurrence Handle1:CAS:528:DyaK1MXltVKjt7k%3D Occurrence Handle10411111

    CAS  PubMed  Google Scholar 

  22. I Pucci-Minafra S Minafra G Rocca ParticleLa et al. (2001) ArticleTitleZymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis Matrix Biol 20 419–27 Occurrence Handle1:CAS:528:DC%2BD3MXnvFGjtLg%3D Occurrence Handle11691582

    CAS  PubMed  Google Scholar 

  23. S Zucker M Hymowitz C Conner et al. (1999) ArticleTitleMeasurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues: clinical and experimental applications Ann N Y Acad Sci 878 212–27 Occurrence Handle1:CAS:528:DyaK1MXkslemsrc%3D Occurrence Handle10415733

    CAS  PubMed  Google Scholar 

  24. DE Kleiner WG Stetler Stevenson (1994) ArticleTitleQuantitative zymography: detection of picogram quantities of gelatinases Anal Biochem 218 325–9 Occurrence Handle10.1006/abio.1994.1186 Occurrence Handle1:CAS:528:DyaK2cXkslKktbk%3D Occurrence Handle8074288

    Article  CAS  PubMed  Google Scholar 

  25. MW Olson MM Bernardo M Pietila et al. (2000) ArticleTitleCharacterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9: differential rates for activation by stromelysin 1 J Biol Chem 275 2661–8 Occurrence Handle1:CAS:528:DC%2BD3cXpvFCnsw%3D%3D Occurrence Handle10644727

    CAS  PubMed  Google Scholar 

  26. N Fujimoto N Mouri K Iwata E Ohuchi Y Okada T Hayakawa (1993) ArticleTitleA one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies Clin Chim Acta 221 91–103 Occurrence Handle1:CAS:528:DyaK2cXhsFOitbY%3D Occurrence Handle8149645

    CAS  PubMed  Google Scholar 

  27. H Sato T Takino Y Okada et al. (1994) ArticleTitleA matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 61–5 Occurrence Handle1:CAS:528:DyaK2cXlvFOhtrs%3D Occurrence Handle8015608

    CAS  PubMed  Google Scholar 

  28. MM Bernardo R Fridman (2003) ArticleTitleTIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP Biochem J 374 739–45 Occurrence Handle1:CAS:528:DC%2BD3sXntFamt74%3D Occurrence Handle12755684

    CAS  PubMed  Google Scholar 

  29. R Visse H Nagase (2003) ArticleTitleMatrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 827–39 Occurrence Handle10.1161/01.RES.0000070112.80711.3D Occurrence Handle1:CAS:528:DC%2BD3sXjtFWqu7c%3D Occurrence Handle12730128

    Article  CAS  PubMed  Google Scholar 

  30. A Pozzi WF LeVine HA Gardner (2002) ArticleTitleLow plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis Oncogene 21 272–81 Occurrence Handle1:CAS:528:DC%2BD38XhtVejt7s%3D Occurrence Handle11803470

    CAS  PubMed  Google Scholar 

  31. AM Sonnante M Correale M Linsalata A Leo ParticleDi V Guerra (2000) ArticleTitleCirculating levels of matrix metalloproteinase-9 in patients with colorectal cancer Scand J Gastroenterol 35 671–2 Occurrence Handle1:STN:280:DC%2BD3M%2FlslChtQ%3D%3D Occurrence Handle10912671

    CAS  PubMed  Google Scholar 

  32. H Ishida N Murata M Tada et al. (2003) ArticleTitleDetermining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer Jpn J Clin Oncol 33 186–91 Occurrence Handle12810833

    PubMed  Google Scholar 

  33. MN Holten Andersen G Murphy HJ Nielsen et al. (1999) ArticleTitleQuantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer Br J Cancer 80 495–503 Occurrence Handle1:STN:280:DyaK1MzhsVOkug%3D%3D Occurrence Handle10408859

    CAS  PubMed  Google Scholar 

  34. P Pellegrini I Contasta AM Berghella E Gargano C Mammarella D Adorno (2000) ArticleTitleSimultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer Cancer Immunol Immunother 49 388–94 Occurrence Handle1:CAS:528:DC%2BD3cXntFCntbc%3D Occurrence Handle10999465

    CAS  PubMed  Google Scholar 

  35. T Hayakawa K Yamashita K Tanzawa E Uchijima K Iwata (1992) ArticleTitleGrowth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum FEBS Lett 298 29–32 Occurrence Handle1:CAS:528:DyaK38Xit1yqsrk%3D Occurrence Handle1544418

    CAS  PubMed  Google Scholar 

  36. AH Baker DR Edwards G Murphy (2002) ArticleTitleMetalloproteinase inhibitors: biological actions and therapeutic opportunities J Cell Sci 115 3719–27 Occurrence Handle1:CAS:528:DC%2BD38XotFemtbs%3D Occurrence Handle12235282

    CAS  PubMed  Google Scholar 

  37. O Kronborg (1999) Screening for colorectal cancer ConfEventName1st Nordic Symposium on Colorectal Cancer, Colorectal Cancer, Current Status and Future Perspectives Bohm Offset Copenhagen 21–47

    Google Scholar 

  38. M Murashige M Miyahara N Shiraishi T Saito K Kohno M Kobayashi (1996) ArticleTitleEnhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors Jpn J Clin Oncol 26 303–9 Occurrence Handle1:STN:280:ByiD2M%2FptlQ%3D Occurrence Handle8895669

    CAS  PubMed  Google Scholar 

  39. AH Ree VA Florenes JP Berg GM Maelandsmo JM Nesland O Fodstad (1997) ArticleTitleHigh levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases Clin Cancer Res 3 1623–8 Occurrence Handle1:STN:280:DyaK1M7htFWjsw%3D%3D Occurrence Handle9815852

    CAS  PubMed  Google Scholar 

  40. KM Fong Y Kida PV Zimmerman PJ Smith (1996) ArticleTitleTIMP1 and adverse prognosis in non-small cell lung cancer Clin Cancer Res 2 1369–72 Occurrence Handle1:STN:280:DyaK1M%2FjsFWmtQ%3D%3D Occurrence Handle9816309

    CAS  PubMed  Google Scholar 

  41. S Ylisirnio M Hoyhtya HT Turpeenniemi (2000) ArticleTitleSerum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer: TIMP-1 as a prognostic marker Anticancer Res 20 1311–6 Occurrence Handle1:CAS:528:DC%2BD3cXjtl2rtrY%3D Occurrence Handle10810441

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University Medical Center Nijmegen, Nijmegen, The Netherlands

    Erwin T. Waas M.Sc., Thijs Hendriks Ph.D., Roger M. L. M. Lomme & Theo Wobbes M.D., Ph.D.

Authors
  1. Erwin T. Waas M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thijs Hendriks Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger M. L. M. Lomme
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Theo Wobbes M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thijs Hendriks Ph.D..

Additional information

This work was supported by the Dutch Cancer Society (grant KUN 97-1380).

About this article

Cite this article

Waas, E., Hendriks, T., Lomme, R. et al. Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients. Dis Colon Rectum 48, 700–710 (2005). https://doi.org/10.1007/s10350-004-0854-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-004-0854-y

Key words

Search

Navigation